david penson

david penson

Vanderbilt University

H-index: 89

North America-United States

About david penson

david penson, With an exceptional h-index of 89 and a recent h-index of 54 (since 2020), a distinguished researcher at Vanderbilt University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Functional Outcomes After Localized Prostate Cancer Treatment

PD58-12 FINANCIAL TOXICITY IN NON-METASTATIC VERSUS METASTATIC RENAL CELL CARCINOMA PATIENTS

Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 5-year follow up

What is cancer? A focus on Grade Group 1 prostate cancer

The Patient Perspective on Colectomy for Recurrent Diverticulitis: A Qualitative Study

A Pragmatic Approach to Prostate Cancer Screening

Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer

Health system perspective on cost for delivering a decision aid for prostate cancer using time-driven activity-based costing

david penson Information

University

Position

___

Citations(all)

40077

Citations(since 2020)

16018

Cited By

30724

hIndex(all)

89

hIndex(since 2020)

54

i10Index(all)

299

i10Index(since 2020)

212

Email

University Profile Page

Vanderbilt University

Google Scholar

View Google Scholar Profile

Top articles of david penson

Title

Journal

Author(s)

Publication Date

Functional Outcomes After Localized Prostate Cancer Treatment

JAMA

Bashir Al Hussein Al Awamlh

Christopher JD Wallis

David F Penson

Li-Ching Huang

Zhiguo Zhao

...

2024/1/23

PD58-12 FINANCIAL TOXICITY IN NON-METASTATIC VERSUS METASTATIC RENAL CELL CARCINOMA PATIENTS

The Journal of Urology

Michael D Staehler

Ulka Vaishampayan

Sumanta K Pal

Pavlos Msaouel

Ithaar Derweesh

...

2024/5

Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 5-year follow up

Christian Pavlovich

Scott Eggener

Michael Koch

David Penson

James Relle

...

2023

What is cancer? A focus on Grade Group 1 prostate cancer

Ruchika Talwar

Olutiwa Akinsola

David F Penson

2024/1/16

The Patient Perspective on Colectomy for Recurrent Diverticulitis: A Qualitative Study

Annals of Surgery

Alexander T Hawkins

David F Penson

Timothy M Geiger

Kemberlee R Bonnet

Matthew G Mutch

...

2024/2/6

A Pragmatic Approach to Prostate Cancer Screening

JAMA

Jeffrey J Tosoian

David F Penson

Arul M Chinnaiyan

2024/4/6

Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer

Prostate Cancer and Prostatic Diseases

Jacob E Tallman

Christopher JD Wallis

Li-Ching Huang

Zhiguo Zhao

David F Penson

...

2023/3

Health system perspective on cost for delivering a decision aid for prostate cancer using time-driven activity-based costing

Medical Care

David R Ho

Robert Kaplan

Jonathan Bergman

David F Penson

Benjamin Waterman

...

2023/10/1

MP54-06 EFFECT OF SMOKING ON PROSTATE CANCER SURVIVORS'FUNCTION AND QUALITY OF LIFE: AN ANALYSIS OF THE CEASAR (COMPARATIVE EFFECTIVENESS ANALYSIS OF SURGERY AND RADIATION) STUDY

The Journal of Urology

David-Dan Nguyen

Daniel A Barocas

Li-Ching Huang

Zhiguo Zhao

Karen E Hoffman

...

2023/4

Effects of specialist palliative care for patients undergoing major abdominal surgery for cancer: a randomized clinical trial

JAMA surgery

Myrick C Shinall

Sara F Martin

Mohana Karlekar

Aimee Hoskins

Ellis Morgan

...

2023/7/1

Financial toxicity and coping mechanisms in patients with metastatic prostate cancer: A pilot study.

Daniel D Joyce

Phillip J Schulte

Eugene D Kwon

Stacie B Dusetzina

David F Penson

...

2023/2/20

Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer

Prostate cancer and prostatic diseases

Jacob E Tallman

Christopher JD Wallis

Li-Ching Huang

Zhiguo Zhao

David F Penson

...

2023/3

MP29-05 TREATMENT PATTERN AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN THE UNITED STATES (US)

The Journal of Urology

Neal Shore

Lawrence Karsh

Daniel Shevrin

James Symanowski

Daniel Lin

...

2023/4

Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer

Prostate Cancer and Prostatic Diseases

Jacob E Tallman

Christopher JD Wallis

Zhiguo Zhao

Li-Ching Huang

David F Penson

...

2023/12

Estimating the impact of the Inflation Reduction Act on the out-of-pocket costs for Medicare beneficiaries with advanced prostate cancer

Urology Practice

Brian D Cortese

Stacie B Dusetzina

Bashir Al Hussein Al Awamlh

David F Penson

Sam S Chang

...

2023/9

Point-Counterpoint: Clinical Pragmatism Should Prevail Over Biological Orthodoxy:“Pro” Perspective

Journal of Urology

David F Penson

Jeffrey J Tosoian

2023/7/1

Association between body mass index and localized prostate cancer management and disease‐specific quality of life

BJUI compass

Nathan L Samora

Christopher JD Wallis

Li‐Ching Huang

Jacob E Tallman

Zhiguo Zhao

...

2023/3

Projected savings for generic oncology drugs purchased via Mark Cuban Cost Plus Drug Company versus in Medicare

Journal of Clinical Oncology

Brian D Cortese

Stacie B Dusetzina

Amy N Luckenbaugh

Bashir Al Hussein Al Awamlh

CJ Stimson

...

2023/10/10

MP48-09 LEVERAGING IMPLEMENTATION SCIENCE TO SUCCESSFULLY SCALE A SHARED DECISION MAKING PROGRAM FOR MEN WITH PROSTATE CANCER

The Journal of Urology

Jonathan Bergman

David Penson

David Ho

Lorna Kwan

Kristen Williams

...

2023/4

MP48-18 PATIENT SATISFACTION WITH THE PHYSICIAN RELATIONSHIP IMPACTS THE EFFECTIVENESS OF DECISION AIDS IN MEN WITH PROSTATE CANCER

The Journal of Urology

Patrick Wilson

Jonathon Bergman

Jefersson Villatoro

Lorna Kwan

Kristen Williams

...

2023/4

See List of Professors in david penson University(Vanderbilt University)